tacrolimus

Tacrolimus is a lipid of Polyketides (PK) class. Tacrolimus is associated with abnormalities such as Renal glomerular disease. The involved functions are known as inhibitors, Fungicidal activity, Metabolic Inhibition, Excretory function and Dephosphorylation. Tacrolimus often locates in Hepatic, Mitochondrial matrix and Inner mitochondrial membrane. The associated genes with Tacrolimus are RHOA gene and BGN gene.

Cross Reference

Introduction

To understand associated biological information of tacrolimus, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with tacrolimus?

tacrolimus is suspected in Renal glomerular disease, Candidiasis, Mycoses, PARKINSON DISEASE, LATE-ONSET, Morphologically altered structure, Skin Diseases, Infectious and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with tacrolimus

MeSH term MeSH ID Detail
Body Weight D001835 333 associated lipids
Lung Neoplasms D008175 171 associated lipids
Adenocarcinoma D000230 166 associated lipids
Colonic Neoplasms D003110 161 associated lipids
Edema D004487 152 associated lipids
Carcinoma, Hepatocellular D006528 140 associated lipids
Hemolysis D006461 131 associated lipids
Cell Transformation, Neoplastic D002471 126 associated lipids
Inflammation D007249 119 associated lipids
Hypertension D006973 115 associated lipids
Glioma D005910 112 associated lipids
Weight Gain D015430 101 associated lipids
Insulin Resistance D007333 99 associated lipids
Hypercholesterolemia D006937 91 associated lipids
Diabetes Mellitus D003920 90 associated lipids
Brain Ischemia D002545 89 associated lipids
Seizures D012640 87 associated lipids
Diabetes Mellitus, Type 2 D003924 87 associated lipids
Arteriosclerosis D001161 86 associated lipids
Diabetes Mellitus, Experimental D003921 85 associated lipids
Atherosclerosis D050197 85 associated lipids
Alzheimer Disease D000544 76 associated lipids
Stomach Ulcer D013276 75 associated lipids
Leukemia D007938 74 associated lipids
Hyperlipidemias D006949 73 associated lipids
Colitis D003092 69 associated lipids
Melanoma D008545 69 associated lipids
Liver Cirrhosis D008103 67 associated lipids
Reperfusion Injury D015427 65 associated lipids
Cystic Fibrosis D003550 65 associated lipids
Pain D010146 64 associated lipids
Dermatitis, Contact D003877 59 associated lipids
Weight Loss D015431 56 associated lipids
Diabetes Mellitus, Type 1 D003922 56 associated lipids
Parkinson Disease D010300 53 associated lipids
Nerve Degeneration D009410 53 associated lipids
Leukemia, Myeloid D007951 52 associated lipids
Kidney Failure, Chronic D007676 51 associated lipids
Osteosarcoma D012516 50 associated lipids
Thrombosis D013927 49 associated lipids
Precancerous Conditions D011230 48 associated lipids
Fatty Liver D005234 48 associated lipids
Psoriasis D011565 47 associated lipids
Hypersensitivity, Delayed D006968 43 associated lipids
Lupus Erythematosus, Systemic D008180 43 associated lipids
Leukemia P388 D007941 43 associated lipids
Hyperalgesia D006930 42 associated lipids
Ischemic Attack, Transient D002546 42 associated lipids
Leukemia, Erythroblastic, Acute D004915 41 associated lipids
Arthritis D001168 41 associated lipids
Hypotension D007022 41 associated lipids
Neovascularization, Pathologic D009389 39 associated lipids
Nervous System Diseases D009422 37 associated lipids
Lung Diseases D008171 37 associated lipids
Heart Failure D006333 36 associated lipids
Glomerulonephritis D005921 35 associated lipids
Acne Vulgaris D000152 35 associated lipids
Infarction, Middle Cerebral Artery D020244 35 associated lipids
Fever D005334 35 associated lipids
Neurotoxicity Syndromes D020258 34 associated lipids
Acute Kidney Injury D058186 34 associated lipids
Spinal Cord Injuries D013119 34 associated lipids
Burns D002056 34 associated lipids
Cataract D002386 34 associated lipids
Peripheral Nervous System Diseases D010523 33 associated lipids
Uremia D014511 33 associated lipids
Ventricular Dysfunction, Left D018487 33 associated lipids
Memory Disorders D008569 33 associated lipids
Diarrhea D003967 32 associated lipids
Neurodegenerative Diseases D019636 32 associated lipids
Stroke D020521 32 associated lipids
Cardiomegaly D006332 31 associated lipids
Liver Diseases D008107 31 associated lipids
Catalepsy D002375 30 associated lipids
Dermatitis D003872 30 associated lipids
Drug Eruptions D003875 30 associated lipids
Proteinuria D011507 30 associated lipids
Obesity D009765 29 associated lipids
Kidney Diseases D007674 29 associated lipids
Ventricular Remodeling D020257 28 associated lipids
Autoimmune Diseases D001327 27 associated lipids
Brain Diseases D001927 27 associated lipids
Endotoxemia D019446 27 associated lipids
Encephalomyelitis, Autoimmune, Experimental D004681 26 associated lipids
Cerebrovascular Disorders D002561 25 associated lipids
Ascites D001201 25 associated lipids
Leukemia-Lymphoma, Adult T-Cell D015459 25 associated lipids
Pseudomonas Infections D011552 25 associated lipids
Arthritis, Experimental D001169 24 associated lipids
Colitis, Ulcerative D003093 24 associated lipids
Lymphoma, B-Cell D016393 24 associated lipids
Cardiovascular Diseases D002318 24 associated lipids
Genetic Predisposition to Disease D020022 24 associated lipids
Cystitis D003556 23 associated lipids
Leukemia, T-Cell D015458 23 associated lipids
Cholestasis D002779 23 associated lipids
Neoplasm Invasiveness D009361 23 associated lipids
Fibrosis D005355 23 associated lipids
Erythema D004890 22 associated lipids
Hypoxia-Ischemia, Brain D020925 22 associated lipids
Per page 10 20 50 100 | Total 613

PubChem Associated disorders and diseases

What pathways are associated with tacrolimus

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with tacrolimus?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with tacrolimus?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with tacrolimus?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with tacrolimus?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with tacrolimus?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with tacrolimus

Download all related citations
Per page 10 20 50 100 | Total 15051
Authors Title Published Journal PubMed Link
Springer JE et al. Calcineurin-mediated BAD dephosphorylation activates the caspase-3 apoptotic cascade in traumatic spinal cord injury. 2000 J. Neurosci. pmid:11007881
Lorf T et al. The effect of pantoprazole on tacrolimus and cyclosporin A blood concentration in transplant recipients. 2000 Eur. J. Clin. Pharmacol. pmid:11009056
Bronster DJ et al. Tacrolimus-associated mutism after orthotopic liver transplantation. 2000 Transplantation pmid:11014653
Kaufman DB et al. Simultaneous pancreas-kidney transplantation in the mycophenolate mofetil/tacrolimus era: evolution from induction therapy with bladder drainage to noninduction therapy with enteric drainage. 2000 Surgery pmid:11015108
Miyake K et al. [Tacrolimus administration to a patient with cyclosporine-induced encephalopathy after allogeneic bone marrow transplantation]. 2000 Rinsho Ketsueki pmid:11020982
Hayashi T and Miyamori I [Cyclosporine- and tacrolimus-induced hypertension]. 2000 Nippon Rinsho pmid:11028414
Matsuura M et al. Effect of FTY720, a novel immunosuppressant, on adjuvant-induced arthritis in rats. 2000 Inflamm. Res. pmid:11028757
Marsen TA et al. Differential transcriptional regulation of endothelin-1 by immunosuppressants FK506 and cyclosporin A. 2000 Jul-Aug Fundam Clin Pharmacol pmid:11030448
Toma H [Neurologic disorders in renal transplantation]. 2000 Ryoikibetsu Shokogun Shirizu pmid:11031921
Davis DL and Soldin SJ Identification of ubiquitin as an immunophilin. 2000 Biochem. Biophys. Res. Commun. pmid:11032725
Taylor PJ et al. Simultaneous quantification of tacrolimus and sirolimus, in human blood, by high-performance liquid chromatography-tandem mass spectrometry. 2000 Ther Drug Monit pmid:11034268
van Gelder T et al. Drug interaction between mycophenolate mofetil and tacrolimus detectable within therapeutic mycophenolic acid monitoring in renal transplant patients. 2000 Ther Drug Monit pmid:11034275
Mayer JM et al. Single doses of FK506 and OKT3 reduce severity in early experimental acute pancreatitis. 2000 Eur J Surg pmid:11034471
Shimoyama M et al. Calcineurin inhibitor attenuates the development and induces the regression of cardiac hypertrophy in rats with salt-sensitive hypertension. 2000 Circulation pmid:11034951
Shiraishi S et al. Post-translational reduction of cell surface expression of insulin receptors by cyclosporin A, FK506 and rapamycin in bovine adrenal chromaffin cells. 2000 Neurosci. Lett. pmid:11036198
Shapiro R et al. Simultaneous pancreas-kidney transplantation at the University of Pittsburgh. 1999 Clin Transpl pmid:11038640
Cronin DC et al. Liver transplantation at the University of Chicago. 1999 Clin Transpl pmid:11038642
Nakahama H et al. Co-administration of furosemide augments tacrolimus-induced impairment in kidney function in rats. 2000 Ren Fail pmid:11041285
Przepiorka D et al. Tacrolimus clearance is age-dependent within the pediatric population. 2000 Bone Marrow Transplant. pmid:11041564
Kantrow SP et al. Regulation of tumor necrosis factor cytotoxicity by calcineurin. 2000 FEBS Lett. pmid:11042265
Yano M et al. Altered stoichiometry of FKBP12.6 versus ryanodine receptor as a cause of abnormal Ca(2+) leak through ryanodine receptor in heart failure. 2000 Circulation pmid:11044432
Miyazawa N et al. Protective effect of FK506 in the reperfusion model after short-term occlusion of middle cerebral artery in the rat: assessment by autoradiography using [125I]PK-11195. 2000 Neurol. Res. pmid:11045029
Jiang H et al. Distinct patterns of cytokine gene suppression by the equivalent effective doses of cyclosporine and tacrolimus in rat heart allografts. 2000 Immunobiology pmid:11045663
Ciancio G et al. Partial venous thrombosis of the pancreatic allografts after simultaneous pancreas-kidney transplantation. 2000 Clin Transplant pmid:11048991
Bechstein WO Neurotoxicity of calcineurin inhibitors: impact and clinical management. 2000 Transpl. Int. pmid:11052266
Weimer R et al. Switch from cyclosporine A to tacrolimus in renal transplant recipients: impact on Th1, Th2, and monokine responses. 2000 Hum. Immunol. pmid:11053632
Murayama T and Ogawa Y Selectively suppressed Ca2+-induced Ca2+ release activity of alpha-ryanodine receptor (alpha-RyR) in frog skeletal muscle sarcoplasmic reticulum: potential distinct modes in Ca2+ release between alpha- and beta-RyR. 2001 J. Biol. Chem. pmid:11054412
Ono K et al. Altered interaction of FKBP12.6 with ryanodine receptor as a cause of abnormal Ca(2+) release in heart failure. 2000 Cardiovasc. Res. pmid:11054478
Shitamukai A et al. A positive screening for drugs that specifically inhibit the Ca2+-signaling activity on the basis of the growth promoting effect on a yeast mutant with a peculiar phenotype. 2000 Biosci. Biotechnol. Biochem. pmid:11055400
Molkentin JD Calcineurin and beyond: cardiac hypertrophic signaling. 2000 Circ. Res. pmid:11055975
Sakata Y et al. Calcineurin inhibitor attenuates left ventricular hypertrophy, leading to prevention of heart failure in hypertensive rats. 2000 Circulation pmid:11056104
Bornhövd EC et al. [Immunosuppressive macrolides and their use in dermatology]. 2000 Hautarzt pmid:11057390
Paul C et al. Ascomycins: promising agents for the treatment of inflammatory skin diseases. 2000 Expert Opin Investig Drugs pmid:11060661
Gold BG Neuroimmunophilin ligands: evaluation of their therapeutic potential for the treatment of neurological disorders. 2000 Expert Opin Investig Drugs pmid:11060810
Kuinose M et al. Calcineurin antagonists inhibit interferon-gamma production by downregulation of interleukin-18 in human mixed lymphocyte reactions. 2000 Acta Med. Okayama pmid:11061569
Bandyopadhyay A et al. Calcineurin regulates ryanodine receptor/Ca(2+)-release channels in rat heart. 2000 Biochem. J. pmid:11062058
Mack-Shipman LR et al. Reproductive hormones after pancreas transplantation. 2000 Transplantation pmid:11063337
Chisholm MA et al. Renal transplant patient compliance with free immunosuppressive medications. 2000 Transplantation pmid:11063348
Dominguez J et al. Conversion to rapamycin immunosuppression in renal transplant recipients: report of an initial experience. 2000 Transplantation pmid:11063349
Hernández G et al. Reduction of severe gingival overgrowth in a kidney transplant patient by replacing cyclosporin A with tacrolimus. 2000 J. Periodontol. pmid:11063397
Abramowicz D et al. Immunosuppressive strategies in renal transplantation at the beginning of the third millennium. 2000 Adv. Nephrol. Necker Hosp. pmid:11068631
Bova D et al. Delayed transient neurologic toxicity due to tacrolimus: CT and MRI. 2000 Neuroradiology pmid:11071440
Miyamoto S et al. Signal transduction pathways that contribute to increased protein synthesis during T-cell activation. 2000 Biochim. Biophys. Acta pmid:11072066
Dale S and Shaw J Clinical picture. Eosinophilic pustular folliculitis. 2000 Lancet pmid:11072943
Shimizu K et al. Tacrolimus (FK506) treatment of CD34+ hematopoietic progenitor cells promote the development of dendritic cells that drive CD4+ T cells toward Th2 responses. 2000 J. Leukoc. Biol. pmid:11073101
Griffith EC et al. Yeast three-hybrid system for detecting ligand-receptor interactions. 2000 Meth. Enzymol. pmid:11075340
Soncin F et al. Role of calcium activated kinases and phosphatases in heat shock factor-1 activation. 2000 Int. J. Mol. Med. pmid:11078832
Guo WH et al. Recipient FK506 pretreatment regimens in rat small bowel transplantation: allograft survival, function, and systemic infection. 2000 J. Pediatr. Surg. pmid:11083432
Bathgate AJ et al. Pretransplantation tumor necrosis factor-alpha production predicts acute rejection after liver transplantation. 2000 Liver Transpl. pmid:11084058
Chang GJ et al. Experience with the use of sirolimus in liver transplantation--use in patients for whom calcineurin inhibitors are contraindicated. 2000 Liver Transpl. pmid:11084060